{"id":"https://openalex.org/W4392848014","doi":"https://doi.org/10.1227/neu.0000000000002810_102","title":"Targeted DNA Sequencing Reveals Molecular Factors Associated with Clinical Outcomes in Recurrent Glioblastoma","display_name":"Targeted DNA Sequencing Reveals Molecular Factors Associated with Clinical Outcomes in Recurrent Glioblastoma","publication_year":2024,"publication_date":"2024-03-15","ids":{"openalex":"https://openalex.org/W4392848014","doi":"https://doi.org/10.1227/neu.0000000000002810_102"},"language":"en","primary_location":{"id":"doi:10.1227/neu.0000000000002810_102","doi":"https://doi.org/10.1227/neu.0000000000002810_102","is_oa":false,"landing_page_url":"https://doi.org/10.1227/neu.0000000000002810_102","pdf_url":null,"source":{"id":"https://openalex.org/S111727011","display_name":"Neurosurgery","issn_l":"0148-396X","issn":["0148-396X","1081-1281","1524-4040"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurosurgery","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025575230","display_name":"Nadeem N. Al-Adli","orcid":"https://orcid.org/0000-0001-7803-8103","observed_orcids":["https://orcid.org/0000-0001-7803-8103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadeem Al-Adli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055644612","display_name":"William  C. Chen","orcid":"https://orcid.org/0000-0001-8924-5853","observed_orcids":["https://orcid.org/0000-0001-8924-5853","https://orcid.org/0009-0002-9193-9197","https://orcid.org/0000-0003-4764-5466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005749201","display_name":"Jacob S. Young","orcid":"https://orcid.org/0000-0002-5499-4325","observed_orcids":["https://orcid.org/0000-0002-5499-4325"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob Young","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040844425","display_name":"Kanish Mirchia","orcid":"https://orcid.org/0000-0002-7371-7059","observed_orcids":["https://orcid.org/0000-0002-7371-7059"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kanish Mirchia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018201764","display_name":"Zain Peeran","orcid":"https://orcid.org/0000-0003-1959-7321","observed_orcids":["https://orcid.org/0000-0003-1959-7321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zain Peeran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072259049","display_name":"Steve E. Braunstein","orcid":"https://orcid.org/0000-0002-9841-9357","observed_orcids":["https://orcid.org/0000-0002-9841-9357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Braunstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052983963","display_name":"Arie Perry","orcid":"https://orcid.org/0000-0002-8300-7261","observed_orcids":["https://orcid.org/0000-0002-8300-7261","https://orcid.org/0000-0003-4571-7999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arie Perry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055183757","display_name":"John de Groot","orcid":"https://orcid.org/0000-0003-1454-6461","observed_orcids":["https://orcid.org/0000-0003-1454-6461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John de Groot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007540843","display_name":"David Ronan Raleigh","orcid":"https://orcid.org/0000-0001-9299-8864","observed_orcids":["https://orcid.org/0000-0001-9299-8864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R. Raleigh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088197113","display_name":"J Costello","orcid":"https://orcid.org/0000-0003-3189-584X","observed_orcids":["https://orcid.org/0000-0003-3189-584X","https://orcid.org/0000-0001-7608-0885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Costello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006262715","display_name":"Mitchel Stuart Berger","orcid":"https://orcid.org/0000-0003-1983-4892","observed_orcids":["https://orcid.org/0000-0003-1983-4892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitchel Berger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079425092","display_name":"Harish N. Vasudevan","orcid":"https://orcid.org/0000-0001-9633-1100","observed_orcids":["https://orcid.org/0000-0001-9633-1100","https://orcid.org/0000-0001-9614-4831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harish Vasudevan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03587593,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"Supplement_1","first_page":"199","last_page":"200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/re-resection","display_name":"re-resection","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.6620000004768372},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8650000095367432},{"id":"https://openalex.org/keywords/reirradiation","display_name":"re-irradiation","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pdgfra-mutation","display_name":"PDGFRA mutation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pten-mutation","display_name":"PTEN mutation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7540000081062317},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.878000020980835},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/lomustine","display_name":"lomustine","score":0.7620000243186951},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/molecular-alterations","display_name":"molecular alterations","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9086261987686157},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.835817813873291},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6294741630554199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6216160655021667},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.5999715924263},{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.5946811437606812},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5556356310844421},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.5424114465713501},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5337384939193726},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.5319414734840393},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4810774028301239},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39436039328575134},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2918652892112732},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.18721306324005127},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.15061265230178833},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12566977739334106},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.09121501445770264},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.0},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1227/neu.0000000000002810_102","doi":"https://doi.org/10.1227/neu.0000000000002810_102","is_oa":false,"landing_page_url":"https://doi.org/10.1227/neu.0000000000002810_102","pdf_url":null,"source":{"id":"https://openalex.org/S111727011","display_name":"Neurosurgery","issn_l":"0148-396X","issn":["0148-396X","1081-1281","1524-4040"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurosurgery","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388588507","https://openalex.org/W4239840346","https://openalex.org/W2887616160","https://openalex.org/W3120851703","https://openalex.org/W4246814916","https://openalex.org/W2890605299","https://openalex.org/W6940823245","https://openalex.org/W4317479144","https://openalex.org/W3169207933","https://openalex.org/W2988076983"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"prognostic":[2],"significance":[3],"of":[4,48,232,279],"molecular":[5,292],"alterations":[6],"in":[7,163,205,244,271,301],"recurrent":[8],"glioblastoma":[9,16],"(rGBM)":[10],"remains":[11],"unclear.":[12],"METHODS:":[13],"121":[14],"consecutive":[15],"(GBM)":[17],"patients":[18,32],"who":[19],"underwent":[20,33],"re-resection":[21,54,74,101,226],"at":[22,46,88],"a":[23,59,268,272],"single":[24],"institution":[25],"from":[26,53,73,100],"2016-2021":[27],"were":[28,56,75,135,220],"retrospectively":[29],"reviewed.":[30],"All":[31],"maximal":[34],"safe":[35],"resection":[36],"followed":[37],"by":[38],"radiotherapy":[39],"with":[40,58,77,222,295],"concurrent":[41],"and":[42,69,81,96,132,137,158,203,242,274,297],"adjuvant":[43],"temozolomide":[44,113],"(TMZ)":[45,114],"time":[47],"initial":[49],"diagnosis.":[50],"DNA":[51,64],"mutations":[52,204,243],"samples":[55],"assessed":[57],"CLIA":[60],"certified":[61],"next-generation":[62],"targeted":[63,218],"sequencing":[65,219],"assay.":[66],"Overall":[67],"(OS)":[68],"progression-free":[70],"survival":[71,296],"(PFS)":[72],"analyzed":[76],"the":[78,206,260],"Kaplan-Meier":[79],"method":[80],"Cox":[82],"regression":[83],"analyses.":[84],"RESULTS:":[85],"Median":[86,130,141],"age":[87],"first":[89],"recurrence":[90],"was":[91,102,146,154,161,169],"57":[92],"years":[93],"(range,":[94,149,156],"27-78),":[95],"median":[97],"follow":[98],"up":[99],"11":[103],"months.":[104],"Salvage":[105],"therapy":[106],"comprised":[107],"re-irradiation":[108,183,199,233,300],"(n":[109,115,120,126],"=":[110,116,121,127],"52,":[111],"43%),":[112],"39,":[117],"32%),":[118],"lomustine":[119],"47,":[122],"39%),":[123],"and/or":[124,182],"bevacizumab":[125],"22,":[128],"18%).":[129],"OS":[131,168,224],"PFS":[133],"times":[134],"12.1":[136],"4.4":[138],"months,":[139],"respectively.":[140],"tumor":[142],"mutation":[143,273],"burden":[144],"(TMB)":[145],"4":[147,281],"mut/Mb":[148],"1-650),":[150],"microsatellite":[151],"instability":[152],"(MSI)":[153],"1.16%":[155],"0-20),":[157],"MGMT":[159],"methylation":[160],"present":[162],"71":[164],"(59%)":[165],"patients.":[166],"Longer":[167],"found":[170],"after":[171,225],"postoperative":[172],"TMZ":[173,195],"(19.1":[174],"vs.":[175,180,185],"9.1),":[176],"KPS":[177],">70":[178],"(13.6":[179],"11.1),":[181],"(12.6":[184],"8.4)":[186],"(p":[187,227],"<":[188,228],".05":[189],"for":[190],"each).":[191],"On":[192],"multivariate":[193],"analysis,":[194],"(HR":[196,200,208,213,239,246,250,255],"0.2,":[197],"0.079-0.48),":[198],"0.27,":[201],"0.12-0.58),":[202],"PDGFRA":[207,245],"0.24,":[209],"0.067-0.83)":[210],"or":[211,253],"PTEN":[212],"2.3,":[214],"1.1-4.8)":[215],"genes":[216],"on":[217],"associated":[221,294],"longer":[223],".05).":[229],"Multivariate":[230],"predictors":[231],"response":[234,298],"included":[235],"MSI":[236],">":[237],"1.16":[238],"0.25,":[240],"0.084-0.75),":[241],"0.04,":[247],"0.005-0.33),":[248],"TERT":[249],"0.16,":[251],"0.033-0.78),":[252],"PIK3R1":[254],"0.18,":[256],"0.041-0.8)":[257],"genes.":[258],"In":[259],"46":[261],"matched":[262],"primary/recurrent":[263],"tumors,":[264],"40":[265],"(46%)":[266],"had":[267,283],"longitudinal":[269],"change":[270],"9":[275],"(24%)":[276],"demonstrated":[277],"hypermutation,":[278],"which":[280],"(57%)":[282],"simultaneous":[284],"mismatch":[285],"repair":[286],"deficiencies.":[287],"CONCLUSIONS:":[288],"Our":[289],"study":[290],"identifies":[291],"factors":[293],"to":[299],"rGBM.":[302]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-03-16T00:00:00"}